Andrew R. Marks, MD
Affiliations: | Physiology | Columbia University College of Physicians and Surgeons, New York, NY, United States |
Area:
Ion channels, Ryanodine receptor biology, rapamycin resistanceWebsite:
http://www.markslab.columbia.eduGoogle:
"Andrew R Marks Chair"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Todd JJ, Lawal TA, Chrismer IC, et al. (2024) Rycal S48168 (ARM210) for -related myopathies: a phase one, open-label, dose-escalation trial. Eclinicalmedicine. 68: 102433 |
| Souidi M, Resta J, Dridi H, et al. (2024) Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy. Journal of Cachexia, Sarcopenia and Muscle |
| Dridi H, Santulli G, Bahlouli L, et al. (2023) Mitochondrial Calcium Overload Plays a Causal Role in Oxidative Stress in the Failing Heart. Biomolecules. 13 |
| Dridi H, Liu Y, Reiken S, et al. (2023) Heart failure-induced cognitive dysfunction is mediated by intracellular Ca leak through ryanodine receptor type 2. Nature Neuroscience |
| Martuscello RT, Chen ML, Reiken S, et al. (2023) Defective cerebellar ryanodine receptor type 1 and endoplasmic reticulum calcium 'leak' in tremor pathophysiology. Acta Neuropathologica |
| Marks AR. (2023) Targeting ryanodine receptors to treat human diseases. The Journal of Clinical Investigation. 133 |
| Miotto MC, Weninger G, Dridi H, et al. (2022) Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Science Advances. 8: eabo1272 |
| Melville Z, Dridi H, Yuan Q, et al. (2022) A drug and ATP binding site in type 1 ryanodine receptor. Structure (London, England : 1993) |
| Dridi H, Forrester F, Umanskaya A, et al. (2022) Role of oxidation of excitation-contraction coupling machinery in age-dependent loss of muscle function in . Elife. 11 |
| Dridi H, Santulli G, Gambardella J, et al. (2022) IP3 receptor orchestrates maladaptive vascular responses in heart failure. The Journal of Clinical Investigation. 132 |